Beta Bionics (BBNX) CFO Stephen Feider Sells 6,675 Shares

What Happened

• Stephen Feider, Chief Financial Officer of Beta Bionics (BBNX), sold 6,675 shares on 2026-09-02 for total proceeds of approximately $127,580. The weighted average sale price reported was $19.1131 (individual prices ranged from $18.89 to $19.545).
• This transaction is reported as a sale (routine disposition) and, per the filing, the shares were sold to cover tax-withholding obligations arising from the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-09-02; Filing date: 2026-09-03 (filed the next day, appears timely).
• Shares sold: 6,675; Weighted average price: $19.1131; Price range: $18.89–$19.545; Proceeds ≈ $127,580.
• Shares owned after transaction: Not specified in the information provided.
• Footnotes: F1 — sale to cover tax withholding on RSU vesting; F2 — weighted average and price range provided; per-price breakdown available upon request to the SEC or issuer.
• Transaction code: S = Sale.

Context

• Sales made to cover tax withholding on vested RSUs are common and generally considered routine administrative transactions rather than strong signals about an executive’s view of the company’s prospects.
• The filing does not indicate an option exercise, gift, or 10% owner activity — it is a revenue-generating sale tied to compensation tax obligations.